Similar articles

• Rationale behind the development of low molecular weight heparin derivatives.

  Hirsh J, Ofosu F, Buchanan M. Hirsh J, et al. Semin Thromb Hemost. 1985 Jan;11(1):13-6. doi: 10.1055/s-2007-1004352. Semin Thromb Hemost. 1985. PMID: 2579436 Review.
• A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.

  Fischer AM, Barrowcliffe TW, Thomas DP. Fischer AM, et al. Thromb Haemost. 1982 Apr 30;47(2):104-8. Thromb Haemost. 1982. PMID: 6179182
• [Low molecular weight heparins].

  Kher A, Bara L, Samama M. Kher A, et al. Pathol Biol (Paris). 1986 Jan;34(1):61-9. Pathol Biol (Paris). 1986. PMID: 3517772 Review. French.
• The effect of a sulfated polysaccharide on antithrombin III.

  Czapek EE, Kwaan HC, Szczecinski M. Czapek EE, et al. J Lab Clin Med. 1980 Jun;95(6):783-90. J Lab Clin Med. 1980. PMID: 6155418
• Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.

  Aiach M, Roncato M. Aiach M, et al. Semin Thromb Hemost. 1985 Apr;11(2):108-11. doi: 10.1055/s-2007-1004366. Semin Thromb Hemost. 1985. PMID: 4035362 No abstract available.